Tilray Brands (TLRY) Inventory Average (2018 - 2026)
Tilray Brands (TLRY) posted Inventory Average of $287.8 million for Q1 2026, up 1.68% on a QoQ basis from $283.0 million in Q4 2025, and up 8.71% year-over-year from $264.7 million in Q1 2025.
Tilray Brands (TLRY) Inventory Average (2018 - 2026) Analysis & Trends
Tilray Brands' Inventory Average history runs 9 years deep, the most recent figure standing at $287.8 million for Q1 2026.
- Quarterly Inventory Average rose 8.71% year-over-year to $287.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $287.8 million (up 8.71% YoY) and the FY2025 annual result came in at $261.5 million, up 15.54% from the prior year.
- Inventory Average was $287.8 million for Q1 2026 at Tilray Brands, up from $283.0 million in the prior quarter.
- Across five years, Inventory Average topped out at $287.8 million in Q1 2026 and bottomed at $201.7 million in Q2 2023.
- A 5-year average of $251.9 million and a median of $253.2 million in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average retreated 22.26% — and 2024, when it advanced 23.03%.
- Tilray Brands' Inventory Average stood at $242.8 million in 2022, then slipped by 0.17% to $242.4 million in 2023, then rose by 9.39% to $265.2 million in 2024, then climbed by 6.73% to $283.0 million in 2025, then advanced by 1.68% to $287.8 million in 2026.
- Business Quant data shows TLRY's Inventory Average at $287.8 million in Q1 2026, $283.0 million in Q4 2025, and $276.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 287.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 287.75 Mn |
| Nov 30, 2025 | 282.99 Mn |
| Aug 31, 2025 | 276.83 Mn |
| May 31, 2025 | 267.14 Mn |
| Feb 28, 2025 | 264.70 Mn |
| Nov 30, 2024 | 265.15 Mn |
| Aug 31, 2024 | 258.19 Mn |
| May 31, 2024 | 248.11 Mn |
| Feb 29, 2024 | 248.42 Mn |
| Nov 30, 2023 | 242.39 Mn |
| Aug 31, 2023 | 216.31 Mn |
| May 31, 2023 | 201.68 Mn |
| Feb 28, 2023 | 221.87 Mn |
| Nov 30, 2022 | 242.80 Mn |
| Aug 31, 2022 | 245.09 Mn |
| May 31, 2022 | 259.41 Mn |
| Feb 28, 2022 | 253.16 Mn |
| Nov 30, 2021 | 242.26 Mn |
| Aug 31, 2021 | 253.97 Mn |
| May 31, 2020 | 117.68 Mn |